About
Technology
Issues
FAQ
Links
Official Page
TWO YEAR OUTCOMES OF “TREAT AND EXTEND” INTRAVITREAL THERAPY USING AFLIBERCEPT PREFERENTIALLY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.